...
首页> 外文期刊>Vaccine >Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection
【24h】

Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection

机译:扩大BCG的抗原库可提高对气溶胶结核分枝杆菌感染的保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

We have developed a strain of the tuberculosis vaccine Mycobacterium bovis bacille Calmette Guerin (BCG) that secretes high levels of a fusion protein comprising the immunodominant Mycobacterium tuberculosis Ag85B and ESAT-6 (BCG85B-ES). Mice vaccinated with BCG85B-ES were significantly better protected in the lung against aerosol infection with virulent M. tuberculosis than animals immunized with control BCG. The growth characteristic of BCG85B-ES in host tissue was identical to control BCG, suggesting the improved protective efficacy was directly related to the expression of the Ag85B-ESAT-6 fusion protein. These results suggest that BCG85B-ES warrants further investigation to determine its suitability to control tuberculosis in humans.
机译:我们已经开发了一种结核病疫苗牛分枝杆菌杆菌卡梅特·格林(BCG)菌株,该菌株分泌高水平的融合蛋白,其中包括免疫优势性结核分枝杆菌Ag85B和ESAT-6(BCG85B-ES)。与用对照BCG免疫的动物相比,接种BCG85B-ES的小鼠在肺部的保护作用更强,可以抵抗强毒结核分枝杆菌的气溶胶感染。 BCG85B-ES在宿主组织中的生长特性与对照BCG相同,这表明改善的保护功效与Ag85B-ESAT-6融合蛋白的表达直接相关。这些结果表明,BCG85B-ES值得进一步研究,以确定其是否适合控制人类的结核病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号